Kevin M Slawin

Summary

Affiliation: Texas Medical Center
Country: USA

Publications

  1. ncbi request reprint The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer
    Michael W Kattan
    Scott Department of Urology, Baylor College of Medicine, 6535 Fannin St, Houston, TX 77030, USA
    J Clin Oncol 21:3573-9. 2003
  2. ncbi request reprint Development of nomogram to predict acute urinary retention or surgical intervention, with or without dutasteride therapy, in men with benign prostatic hyperplasia
    Kevin M Slawin
    Baylor Prostate Center, Scott Department of Urology, Baylor College of Medicine, Methodist Hospital, Houston, Texas, USA
    Urology 67:84-8. 2006
  3. ncbi request reprint Association of pre- and postoperative plasma levels of transforming growth factor beta(1) and interleukin 6 and its soluble receptor with prostate cancer progression
    Shahrokh F Shariat
    Baylor Prostate Center, Scott Department of Urology, Baylor College of Medicine, and The Methodist Hospital, Houston, Texas 77030, USA
    Clin Cancer Res 10:1992-9. 2004
  4. doi request reprint Pre-treatment biomarker levels improve the accuracy of post-prostatectomy nomogram for prediction of biochemical recurrence
    Robert S Svatek
    Department of Urology, University of Texas Southwestern Medical Centre, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Prostate 69:886-94. 2009
  5. ncbi request reprint Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes
    Shahrokh F Shariat
    Baylor Prostate Center, Scott Department of Urology, Baylor College of Medicine, 6560 Fannin Street, Houston, TX 77030, USA
    Cancer Res 63:4662-70. 2003
  6. ncbi request reprint Biochemical staging of prostate cancer
    Eduardo I Canto
    Scott Department of Urology, 6535 Fannin Street, Fondren 401, Baylor College of Medicine, Houston, TX 77030, USA
    Urol Clin North Am 30:263-77. 2003
  7. ncbi request reprint Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy
    Shahrokh F Shariat
    Matsunaga Conte Prostate Cancer Research Center, Scott Department of Urology, Baylor College of Medicine and The Methodist Hospital, Houston, Texas 77030, USA
    Cancer Res 63:5874-8. 2003
  8. ncbi request reprint Detection of clinically significant, occult prostate cancer metastases in lymph nodes using a splice variant-specific rt-PCR assay for human glandular kallikrein
    Shahrokh F Shariat
    Baylor Prostate Center, the Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA
    J Clin Oncol 21:1223-31. 2003
  9. ncbi request reprint Tissue expression of transforming growth factor-beta1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy
    Shahrokh F Shariat
    Baylor Prostate Center, Scott Department of Urology, Baylor College of Medicine and Methodist Hospital, Houston, Texas 77030, USA
    Urology 63:1191-7. 2004
  10. ncbi request reprint Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder
    Shahrokh F Shariat
    Scott Department of Urology, Baylor College of Medicine and Methodist Hospital, Houston, Texas 77030, USA
    Urology 61:1053-8. 2003

Collaborators

Detail Information

Publications59

  1. ncbi request reprint The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer
    Michael W Kattan
    Scott Department of Urology, Baylor College of Medicine, 6535 Fannin St, Houston, TX 77030, USA
    J Clin Oncol 21:3573-9. 2003
    ....
  2. ncbi request reprint Development of nomogram to predict acute urinary retention or surgical intervention, with or without dutasteride therapy, in men with benign prostatic hyperplasia
    Kevin M Slawin
    Baylor Prostate Center, Scott Department of Urology, Baylor College of Medicine, Methodist Hospital, Houston, Texas, USA
    Urology 67:84-8. 2006
    ....
  3. ncbi request reprint Association of pre- and postoperative plasma levels of transforming growth factor beta(1) and interleukin 6 and its soluble receptor with prostate cancer progression
    Shahrokh F Shariat
    Baylor Prostate Center, Scott Department of Urology, Baylor College of Medicine, and The Methodist Hospital, Houston, Texas 77030, USA
    Clin Cancer Res 10:1992-9. 2004
    ..The objectives of this study were to confirm these findings and to examine the association of changes in plasma levels of these markers after surgery with disease progression in a large consecutive cohort of patients...
  4. doi request reprint Pre-treatment biomarker levels improve the accuracy of post-prostatectomy nomogram for prediction of biochemical recurrence
    Robert S Svatek
    Department of Urology, University of Texas Southwestern Medical Centre, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Prostate 69:886-94. 2009
    ..We tested the ability of several pre-operative blood-based biomarkers to enhance the accuracy of standard post-operative features for the prediction of biochemical recurrence (BCR) after radical prostatectomy (RP)...
  5. ncbi request reprint Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes
    Shahrokh F Shariat
    Baylor Prostate Center, Scott Department of Urology, Baylor College of Medicine, 6560 Fannin Street, Houston, TX 77030, USA
    Cancer Res 63:4662-70. 2003
    ..In pT(3)N(0) patients, a positive RT-PCR-hK2 assay result when performed on PLN was the strongest predictor of clinical outcomes after radical prostatectomy...
  6. ncbi request reprint Biochemical staging of prostate cancer
    Eduardo I Canto
    Scott Department of Urology, 6535 Fannin Street, Fondren 401, Baylor College of Medicine, Houston, TX 77030, USA
    Urol Clin North Am 30:263-77. 2003
    ..Incorporating these new markers into nomograms will enhance the ability to provide optimal care for each prostate cancer patient...
  7. ncbi request reprint Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy
    Shahrokh F Shariat
    Matsunaga Conte Prostate Cancer Research Center, Scott Department of Urology, Baylor College of Medicine and The Methodist Hospital, Houston, Texas 77030, USA
    Cancer Res 63:5874-8. 2003
    ....
  8. ncbi request reprint Detection of clinically significant, occult prostate cancer metastases in lymph nodes using a splice variant-specific rt-PCR assay for human glandular kallikrein
    Shahrokh F Shariat
    Baylor Prostate Center, the Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA
    J Clin Oncol 21:1223-31. 2003
    ....
  9. ncbi request reprint Tissue expression of transforming growth factor-beta1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy
    Shahrokh F Shariat
    Baylor Prostate Center, Scott Department of Urology, Baylor College of Medicine and Methodist Hospital, Houston, Texas 77030, USA
    Urology 63:1191-7. 2004
    ....
  10. ncbi request reprint Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder
    Shahrokh F Shariat
    Scott Department of Urology, Baylor College of Medicine and Methodist Hospital, Houston, Texas 77030, USA
    Urology 61:1053-8. 2003
    ..We tested the hypothesis that preoperative plasma levels of uPA and its specific receptor, uPAR, would predict cancer stage and prognosis in patients with transitional cell carcinoma of the bladder...
  11. ncbi request reprint Effects of systematic 12-core biopsy on the performance of percent free prostate specific antigen for prostate cancer detection
    Eduardo I Canto
    Baylor Prostate Center, Scott Department of Urology, Baylor College of Medicine, 6560 Fannin Street, Houston, TX 77030, USA
    J Urol 172:900-4. 2004
    ..We determined whether the addition of 6 laterally directed cores to the traditional sextant prostate biopsy affects the performance of percent fPSA...
  12. ncbi request reprint Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy
    Shahrokh F Shariat
    Matsunaga Conte Prostate Cancer Research Center, Scott Department of Urology, Baylor College of Medicine and The Methodist Hospital, Houston, Texas 77030, USA
    Cancer Res 62:5974-9. 2002
    ..In contrast, preoperative RT-PCR-hK2-L status is associated with established markers of aggressive prostate cancer...
  13. ncbi request reprint Enhanced activation of human dendritic cells by inducible CD40 and Toll-like receptor-4 ligation
    Natalia Lapteva
    Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA
    Cancer Res 67:10528-37. 2007
    ....
  14. ncbi request reprint Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer
    Eduardo I Canto
    Baylor Prostate Center, Scott Department of Urology, Baylor College of Medicine, Houston, Texas 77030, USA
    Urology 63:905-10; discussion 910-1. 2004
    ....
  15. ncbi request reprint Correlation of preoperative levels of IGF-I and IGFBP-3 with pathologic parameters and clinical outcome in patients with bladder cancer
    Shahrokh F Shariat
    Baylor Prostate Center, Scott Department of Urology, Baylor College of Medicine, and Methodist Hospital, Houston, Texas 77030 2706, USA
    Urology 61:359-64. 2003
    ..The IGFs are mitogens that have been shown to play a significant role in regulating proliferation and differentiation of bladder cancer cells...
  16. ncbi request reprint Preoperative plasma soluble E-cadherin predicts metastases to lymph nodes and prognosis in patients undergoing radical cystectomy
    Kazumasa Matsumoto
    Scott Department of Urology, Baylor College of Medicine, Houston, Texas 77030, USA
    J Urol 170:2248-52. 2003
    ..We determined whether plasma levels of sE-cadherin are associated with bladder cancer stage and prognosis...
  17. ncbi request reprint Predictors of prostate cancer after initial negative systematic 12 core biopsy
    Herb Singh
    Baylor Prostate Center, Scott Department of Urology, Houston, Texas 77030, USA
    J Urol 171:1850-4. 2004
    ....
  18. ncbi request reprint Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy
    Shahrokh F Shariat
    Baylor Prostate Center and Division of Male Reproductive Medicine, Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA
    J Clin Oncol 22:1655-63. 2004
    ....
  19. ncbi request reprint Versatile prostate cancer treatment with inducible caspase and interleukin-12
    Ekaterina Yu Nikitina
    Department of Immunology and Scott Department of Urology, Baylor College of Medicine, Texas Medical Center, Houston, Texas 77030, USA
    Cancer Res 65:4309-19. 2005
    ..Thus, tumor cell apoptosis induced by caspase in situ and accompanied by IL-12 is efficient against prostate cancer in a preclinical model...
  20. ncbi request reprint Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy
    Herb Singh
    Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA
    J Urol 171:1089-92. 2004
    ....
  21. ncbi request reprint Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis
    Shahrokh F Shariat
    Baylor Prostate Center and Male Reproductive Medicine and Surgery, Baylor College of Medicine and The Methodist Hospital, Houston, TX 77030, USA
    J Clin Oncol 20:833-41. 2002
    ..We tested the hypothesis that preoperative plasma levels of insulin-like growth factor (IGF) binding protein (BP)-2 or IGFBP-3 would predict cancer stage and prognosis in patients undergoing radical prostatectomy...
  22. pmc A composite MyD88/CD40 switch synergistically activates mouse and human dendritic cells for enhanced antitumor efficacy
    Priyadharshini Narayanan
    Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas 77030, USA
    J Clin Invest 121:1524-34. 2011
    ....
  23. ncbi request reprint Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer
    Ben Andrews
    Scott Department of Urology, Baylor College of Medicine and The Methodist Hospital, Houston, Texas, USA
    J Urol 167:1475-81. 2002
    ..We tested the hypothesis that preoperative plasma IL-6 and IL-6sR levels would predict cancer stage and prognosis in patients with transitional cell carcinoma of the bladder...
  24. ncbi request reprint Impact of unilateral interposition sural nerve grafting on recovery of urinary function after radical prostatectomy
    Herb Singh
    Baylor Prostate Center, Scott Department of Urology, Baylor College of Medicine, Houston, Texas 77030, USA
    Urology 63:1122-7. 2004
    ..To test the hypothesis that unilateral sural nerve graft (SNG) interposition may improve the rate of urinary function (UF) recovery after radical retropubic prostatectomy (RRP) in patients undergoing unilateral nerve resection (UNR)...
  25. ncbi request reprint Molecular diagnosis of prostate cancer
    Eduardo I Canto
    Scott Department of Urology, Baylor College of Medicine, The Baylor Prostate Center, 6560 Fannin Street, Suite 2100, Houston, TX 77030, USA
    Curr Urol Rep 5:203-11. 2004
    ....
  26. ncbi request reprint Six additional systematic lateral cores enhance sextant biopsy prediction of pathological features at radical prostatectomy
    Herb Singh
    Baylor Prostate Center, Scott Department of Urology, Baylor College of Medicine, Houston, Texas 77030, USA
    J Urol 171:204-9. 2004
    ..We evaluated the contribution of 6 additional systematically obtained, laterally directed biopsy cores to traditional sextant biopsy for the prediction of final pathological findings in the radical prostatectomy specimen...
  27. doi request reprint The phosphatase SRC homology region 2 domain-containing phosphatase-1 is an intrinsic central regulator of dendritic cell function
    Indu R Ramachandran
    Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA
    J Immunol 186:3934-45. 2011
    ..Taken together, these data demonstrate that SHP-1 is an intrinsic global regulator of DC function, controlling many facets of T cell-mediated immune responses...
  28. ncbi request reprint Prostate-specific antigen and prostate-specific antigen derivatives as predictors of benign prostatic hyperplasia progression
    Jonathan M Levitt
    The Baylor Prostate Center, Scott Department of Urology, Baylor College of Medicine, 6560 Fannin Street, Suite 2100, Houston, TX 77030, USA
    Curr Urol Rep 8:269-74. 2007
    ..Herein we review the expression, processing, and biochemistry of PSA and its derivatives and discuss the potential of these isoforms, both individually and in combination, to serve as determinants of BPH severity and progression...
  29. ncbi request reprint Variation in prostate specific antigen results from 2 different assay platforms: clinical impact on 2304 patients undergoing prostate cancer screening
    Richard E Link
    Scott Department of Urology, Baylor College of Medicine and Methodist Hospital, Houston, Texas 77030, USA
    J Urol 171:2234-8. 2004
    ..The contribution of cross-platform variation to these fluctuations is not well understood. To address this question we performed a cross-sectional study comparing 2 popular PSA assays during prostate cancer screening...
  30. ncbi request reprint The EZC-prostate model: noninvasive prostate imaging in living mice
    Xiaoming Xie
    Department of Immunology, Baylor College of Medicine, One Baylor Plaza M929, Houston, Texas 77030, USA
    Mol Endocrinol 18:722-32. 2004
    ....
  31. ncbi request reprint Pilot study of radiofrequency interstitial tumor ablation (RITA) for the treatment of radio-recurrent prostate cancer
    Shahrokh F Shariat
    Baylor Prostate Center, Scott Department of Urology, Baylor College of Medicine, and The Methodist Hospital, Houston, Texas 77030, USA
    Prostate 65:260-7. 2005
    ..To prospectively evaluate the feasibility, safety, morbidity, and preliminary efficacy of radiofrequency interstitial tumor ablation (RITA) for the focal treatment of patients with local prostate cancer recurrence...
  32. ncbi request reprint An essential role for Akt1 in dendritic cell function and tumor immunotherapy
    Dongsu Park
    Department Immunology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA
    Nat Biotechnol 24:1581-90. 2006
    ..Thus, Akt1 is a critical regulator of DC lifespan, and its manipulation in DCs can improve the clinical efficacy of DC-based tumor vaccines...
  33. ncbi request reprint Vaccine therapy for prostate cancer
    Guru Sonpavde
    U S Oncology Research and the Department of Medicine, Section of Medical Oncology, Baylor College of Medicine, Houston, TX 77598, USA
    Urol Oncol 25:451-9. 2007
    ..Efforts to optimize vaccine approaches and select ideal patient populations need to continue because there is no evidence supporting a single superior approach...
  34. ncbi request reprint Early management of prostate cancer: how to respond to an elevated PSA?
    Eduardo I Canto
    Scott Department of Urology, Baylor College of Medicine, Houston, Texas 77030, USA
    Annu Rev Med 53:355-68. 2002
    ..Furthermore, those with a significant change in either DRE or PSA results, or those at higher risk for prostate cancer with a PSA level above 2.5 ng/ml, should also be referred for evaluation...
  35. pmc MyD88/CD40 Genetic Adjuvant Function in Cutaneous Atypical Antigen-Presenting Cells Contributes to DNA Vaccine Immunogenicity
    Matthew R Collinson-Pautz
    Interdepartmental Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, TX, United States of America
    PLoS ONE 11:e0164547. 2016
    ....
  36. ncbi request reprint Newer modalities of ultrasound imaging and treatment of the prostate
    Gilad E Amiel
    Baylor Prostate Center, Scott Department of Urology, Baylor College of Medicine, 6560 Fannin, Suite 2100, Houston, TX 77030, USA
    Urol Clin North Am 33:329-37. 2006
    ..In addition, treatment modalities using ultrasound for the treatment of BPH have been developed. This review presents the recent developments in ultrasound of the prostate...
  37. ncbi request reprint Re-engineered CD40 receptor enables potent pharmacological activation of dendritic-cell cancer vaccines in vivo
    Brent A Hanks
    Department of Immunology, Baylor College of Medicine, Houston, Texas 77030, USA
    Nat Med 11:130-7. 2005
    ....
  38. ncbi request reprint Prognostic significance of location of positive margins in radical prostatectomy specimens
    James A Eastham
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Urology 70:965-9. 2007
    ..In this study, we assessed the prognostic significance of sites of positive surgical margins (+SMs) in RP specimens...
  39. doi request reprint Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer
    Jose A Karam
    Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
    Clin Cancer Res 14:1418-22. 2008
    ..The aim of the study was to evaluate whether preoperative plasma endoglin improves the prediction of lymph node metastases in patients with clinically localized prostate cancer...
  40. ncbi request reprint Preoperative plasma HER2 and epidermal growth factor receptor for staging and prognostication in patients with clinically localized prostate cancer
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390 9110, USA
    Clin Cancer Res 13:5377-84. 2007
    ..We tested the hypothesis that plasma levels of HER2 and/or EGFR are associated with prostate cancer stage and prognosis in patients with clinically localized disease...
  41. doi request reprint Preoperative plasma endoglin levels predict biochemical progression after radical prostatectomy
    Robert S Svatek
    Department of Urology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390 9110, USA
    Clin Cancer Res 14:3362-6. 2008
    ..The aim of this study was to evaluate the association of preoperative plasma endoglin levels with established clinical and pathologic features of prostate cancer and disease progression after radical prostatectomy...
  42. doi request reprint Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers
    Shahrokh F Shariat
    Authors Affiliations Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas
    Clin Cancer Res 14:3785-91. 2008
    ..The aim of this study was to determine the added value of biomarkers relative to established predictors of biochemical recurrence, such as clinical stage, biopsy Gleason sum, and preoperative prostate-specific antigen...
  43. ncbi request reprint Survivin expression is associated with features of biologically aggressive prostate carcinoma
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 91120, USA
    Cancer 100:751-7. 2004
    ....
  44. ncbi request reprint Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors
    Michael W Kattan
    Department of Urology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Urol 170:1792-7. 2003
    ....
  45. ncbi request reprint Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    JAMA 291:1325-32. 2004
    ..Salvage radiotherapy may potentially cure patients with disease recurrence after radical prostatectomy, but previous evidence has suggested that it is ineffective in patients at the highest risk of metastatic disease progression...
  46. ncbi request reprint Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer
    Makoto Ohori
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 171:1844-9; discussion 1849. 2004
    ..We developed a model to predict the side specific probability of extracapsular extension (ECE) in radical prostatectomy (RP) specimens based on the clinical features of the cancer...
  47. ncbi request reprint Is tumor volume an independent prognostic factor in clinically localized prostate cancer?
    Eiji Kikuchi
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Urol 172:508-11. 2004
    ..We assessed the prognostic significance of TV in a large series of patients followed for a long time to discover whether the effect of TV has changed with earlier detection of smaller tumors...
  48. ncbi request reprint Plasminogen activation inhibitor-1 improves the predictive accuracy of prostate cancer nomograms
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
    J Urol 178:1229-36; discussion 1236-7. 2007
    ....
  49. pmc Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
    Andrew J Stephenson
    Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, OH 44195 0001, USA
    J Clin Oncol 25:2035-41. 2007
    ..We developed a nomogram to predict the probability of cancer control at 6 years after SRT for PSA-defined recurrence...
  50. ncbi request reprint Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis
    Shahrokh F Shariat
    Department of Urology, The University of Texas Southwestern Medical Center, Dallas, TX 75390 9110, USA
    J Clin Oncol 25:349-55. 2007
    ..To assess whether preoperative plasma levels of urokinase-type plasminogen activator (uPA) and its soluble receptor (uPAR) would predict cancer of the prostate (CaP) presence, stage, and prognosis...
  51. ncbi request reprint Perspectives on the natural history of recurrent prostate cancer after radical prostatectomy, based on the response to salvage radiotherapy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    BJU Int 94:1210-2. 2004
  52. ncbi request reprint The value of radiotherapy in treating recurrent prostate cancer after radical prostatectomy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Nat Clin Pract Urol 1:90-6. 2004
    ..To be successful, salvage EBRT should be administered at the earliest evidence of recurrent disease, once a rising PSA trend as been confirmed...
  53. ncbi request reprint Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390 9110, USA
    J Urol 174:2046-50. 2005
    ..We assessed the differential expression of survivin and other apoptotic markers in stromal and epithelial compartments of benign prostatic hyperplasia (BPH) and normal prostate tissue...
  54. ncbi request reprint The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia
    John D McConnell
    University of Texas Southwestern Medical Center, Dallas, TX 75390 9110, USA
    N Engl J Med 349:2387-98. 2003
    ..The long-term effect of these drugs, singly or combined, on the risk of clinical progression is unknown...
  55. doi request reprint Notice of duplicate publication: "Potentially harmful effect of a testosterone dietary supplement on prostate cancer growth and metastasis" (arch intern med. 2008;168[2]:235-236)
    Shahrokh F Shariat
    Department of Urology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390 9110
    Arch Intern Med 168:2046-7. 2008
  56. ncbi request reprint Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo
    E David Crawford
    University of Colorado Health Sciences Center, Aurora, Colorado, USA
    J Urol 175:1422-6; discussion 1426-7. 2006
    ..We analyzed data from the placebo arm of the MTOPS trial to determine clinical predictors of BPH progression...
  57. doi request reprint Potentially harmful effect of a testosterone dietary supplement on prostate cancer growth and metastasis
    Shahrokh F Shariat
    Arch Intern Med 168:235-6. 2008
  58. doi request reprint Herbal/hormonal dietary supplement possibly associated with prostate cancer progression
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390 9110, USA
    Clin Cancer Res 14:607-11. 2008
    ..After two men developed an unusual course of clinically aggressive prostate cancer within months of starting daily consumption of the same HHDS product, we investigated the effect of this product on prostate cancer progression...
  59. ncbi request reprint Reliability of remembered International Index of Erectile Function domain scores in men with localized prostate cancer
    Pierre Karakiewicz
    Department of Urology and Outcomes Research Unit, University of Montreal, Montreal, Quebec, Canada
    Urology 65:131-5. 2005
    ..Recall reliability can be affected by several biases. In men with localized prostate cancer (PCa), conflicting results have been reported...